All cancer types
Results
Phase 1
This trial looked at a drug called GSK2816126 for certain types of non-Hodgkin lymphoma (NHL), myeloma and other solid tumours.
This trial was open for people to join between 2015 and 2017. The team published the results in 2019.
Recruitment start: 6 February 2015
Recruitment end: 12 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor P Johnson
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
Last reviewed: 26 May 2021
CRUK internal database number: 12807
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
